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Purpose: COPD remains under-recognized and under-treated. Much of early COPD care is 
given by primary care physicians but only when COPD is recognized. This survey explores 
the attitudes, beliefs, and knowledge related to COPD recognition, diagnosis, and treatment 
from family physicians and nurse practitioners (NPs) and physician assistants (PAs) working 
in primary care.
Methods: We completed a survey of family physicians, and NPs/PAs attending one of three 
CME programs on ﬁ  ve common chronic conditions including COPD.
Results: Return rate was 62% (n = 284) including 178 physicians and 100 NPs/PAs. Fewer 
than half of the respondents reported knowledge of or use of COPD guidelines. The barriers 
to recognition and diagnosis of COPD they reported included the multiple morbidities of most 
COPD patients, failure of patients to report COPD symptoms, as well as lack of knowledge and 
inadequate training in COPD diagnosis and management. Three quarters (74%) of respondents 
reported use of spirometry to diagnose COPD but only 32% said they included reversibility 
assessment. COPD was incorrectly assessed as a disease primarily of men (78% of respondents) 
that appeared after age 60 (61%). Few respondents reported that they believed COPD treatment 
was useful or very useful for improving symptoms (15%) or decreasing exacerbations (3%) or 
that pulmonary rehabilitation was helpful (3%), but  13% reported they thought COPD treat-
ment could extend longevity.
Conclusions: Primary care physicians and NPs/PAs working in primary care continue to report 
lack of awareness and use of COPD guidelines, as well as correct information related to COPD 
epidemiology or potential beneﬁ  ts of available treatments including pulmonary rehabilitation. 
It is unlikely that diagnosis and management of COPD will improve in primary care until these 
knowledge gaps and discrepancies with published efﬁ  cacy of therapy issues are addressed.
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Introduction
Primary care physicians provide all or at least part of the health care for 80% of the 
more than 20 million Americans with recognized and unrecognized chronic obstructive 
pulmonary disease (COPD) (Mannino 2002; GSK 2007). For those with recognized 
COPD, current management is frequently incompatible with recommended care (ATS 
2004; GOLD 2007; NICE 2007) For those who have unrecognized COPD, opportuni-
ties to improve their functional status, quality of life, and prevention of exacerbations 
are missed by failure to recognize the disease (Pena et al 2000; Halbert et al 2003, 
2006; Zaas et al 2004; Lindberg et al 2006).
Among the barriers that may slow the implementation of evidence-based COPD 
management are ambiguous and divergent US recommendations for COPD screening 
(NLHEP 1998; Hardie et al 2002; Bolton et al 2005; Wilt et al 2005; Hansen-Flaschen 
2007; Yawn et al 2007). The lack of well recognized US primary care guidelines for 
the management of diagnosed COPD is another potential barrier to an aggressive 
primary care approach to COPD. The international Global Initiative for Obstructive International Journal of COPD 2008:3(2) 312
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Lung Disease (GOLD) guidelines (GOLD 2007; Hurst and 
Wedzicha 2007), the International Primary Care Respiratory 
Group (IPCRG) COPD guidelines (Levy et al 2006), and the 
American Thoracic Society/European Respiratory Society 
COPD guidelines (ATS/ERS 2004) have received limited 
exposure among US primary care physicians, especially in 
comparison with guidelines for the other major obstructive 
lung disease, asthma.
As part of its effort to collaborate with the National 
Heart Lung and Blood Institute’s (NHLBI) COPD public 
awareness campaign (GOLD 2007), the American Academy 
of Family Physicians (AAFP) included COPD as part of its 
annual clinical focus on ﬁ  ve chronic diseases in 2006–2007 
and sponsored COPD continuing medical education (CME) 
sessions in three major US cities in the summer of 2006. In 
conjunction with those sessions, COPD-related surveys were 
distributed to all attendees. Information from these surveys 
was used to better focus future education programs and as a 
comparison for similar data from generalists practicing in other 
countries such as the United Kingdom and the Netherlands 
where COPD management has received greater primary care 
emphasis (Mulcahy et al 2005; Meulepas et al 2006).
Methods
The attendees of three AAFP sponsored CME programs held 
in Raleigh, NC, Costa Mesa, CA and Chicago, IL were asked 
to complete a brief survey during the 10 minutes immediately 
prior to a 70-min talk on COPD diagnosis and management 
given by one of the authors (BPY). The completed surveys 
were collected during the ﬁ  rst 15 minutes of the talk so that 
little of the information in the talk should have inﬂ  uenced 
the attendees’ responses to the surveys. We therefore believe 
that the information provided is based on attendees’ prior 
knowledge of COPD, not on knowledge gained during the 
lecture.
The overall response rate to the survey varied slightly 
by site from 155 (70%) in Chicago, to 170 (55%) in Costa 
Mesa, and 130 (57%) in Raleigh. The total number of useable 
surveys was 284 out of 455 possible (62% overall).
The survey included questions on demographic infor-
mation: specialty, age (divided into 5 categories), gender, 
and length of time in practice (in 4 categories). Additional 
practice-related information included: practice site (rural/
urban/suburban), practice size (solo, small group – up to 5, 
medium – 6 to 10 and over 10), and practice type (single or 
multi-specialty).
Speciﬁ  c questions about COPD included queries about 
which guidelines the respondent used for COPD, barriers to 
COPD diagnosis, characteristics used to make a diagnosis 
of COPD and testing done for COPD. Two questions about 
rates of smoking in patients in the community and access to 
smoking cessation services were included.
The last set of questions asked about attitudes and beliefs 
related to COPD including differentiation from asthma, 
effectiveness of treatment for COPD symptoms, increasing 
longevity, decreasing exacerbations and the value and acces-
sibility of pulmonary rehabilitation. The ﬁ  nal two questions 
addressed the expected gender and age of symptom-onset 
of COPD patients.
Data were entered into an Excel (Microsoft, Redmond, 
WA) spreadsheet and ﬁ  rst analyzed using simple descrip-
tive statistics to obtain frequencies of responses overall. 
Responses were stratiﬁ  ed in different groupings including 
by site of program (eg, region of country, n = 3), and by 
level of training (physician versus nurse practitioner [NP] 
and physician’s assistant [PA]). Statistical comparisons 
used chi-square and Mantel Haenzel testing. Regression 
models were developed for use of spirometry testing for 
diagnosis of COPD that included respondent’s age, gen-
der, level of training, region of country, and time since 
graduating as the independent variables. Similar models 
were developed for use of reversibility testing and use of 
COPD guidelines.
Results
The attendee respondents whose data were included in the 
analysis (n = 278) were a combination of family physicians 
(n = 178, 63% of respondents), and nonphysician clinicians 
including NPs and PAs (n = 100, 35%). Four respondents 
identiﬁ  ed themselves as “other” and two others who did not 
answer the question were excluded from further analysis. 
The median age was 40–49 years and over half (57%) were 
women (Table 1).
The most commonly reported “COPD” guidelines used 
were the GOLD and ATS/ERS guidelines (n = 133, 47%, either 
one or both). Sixty two people (21%) reporting using none and 
27 (10%) stated that they did not know such guidelines existed. 
Thirty one people (11%) checked that they used the NAEPP 
guidelines for COPD. These are asthma guidelines that do 
not deal with COPD. Lack of awareness of COPD guidelines 
(didn’t know, plus those reporting use of NAEPP guidelines 
for COPD) varied by site of the talk, the qualiﬁ  cations of the 
health professional, their age, and whether or not they had 
spirometry equipment in their ofﬁ  ce (Table 2).
Respondents were asked to mark all barriers they 
experience in diagnosing COPD. The most commonly listed International Journal of COPD 2008:3(2) 313
COPD attitudes to continuing medical education
barriers to the diagnosis of COPD are shown in Table 3 
and include lack of symptoms, failure of patient to report 
symptoms as well as the impact of multiple chronic conditions 
in people with COPD. About one in four respondents admitted 
to inadequate knowledge and training about COPD diagnosis 
and management. Some perceived barriers such as the pres-
ence of multiple morbidities (NP/PAs (64%) vs MDs (45%); 
p = 0.01) and lack of training (NPs/PAs 33% vs M.D. (22%); 
p = 0.06) varied by level of health professional (Table 4).
Frequently reported barriers also varied by region of 
the country. Attendees in Chicago were signiﬁ  cantly less 
likely to report patient failure to report symptoms (37%) 
compared with attendees in Costa Mesa, CA and Raleigh, 
NC (54% and 55%, respectively; p = 0.01). Concerns about 
training were more common among attendees from Costa 
Mesa, CA (35%) than among those from Raleigh, NC (21%) 
(p = 0.01). However, reported use of spirometry did not vary 
by region (Table 2).
While a history of smoking, cough, and dyspnea were 
all considered important in diagnosing COPD, spirometry 
testing results was the most commonly listed factor for 
diagnosing COPD (Table 3). While 76% of the attendees 
stated that they used spirometry for COPD diagnosis and 52% 
(n = 148) said they had spirometry testing available in their 
ofﬁ  ce, only 31% (n = 89) said they used spirometry for all 
COPD diagnoses. Only 91 (32%) respondents (38% of MDs 
vs 23% of NPs/Pas; p = 0.01) reported use of reversibility 
testing for COPD diagnosis (See Table 2).
Other “tests” used for diagnosing COPD included chest 
x-ray, a trial of bronchodilators and a trial of oral steroids 
(Table 2). One in ﬁ  ve, 56 (20%) reported referring all or 
most COPD patients to a lung specialist. Nineteen of the 278 
(7%) reported regular use of alpha-one antitrypsin levels in 
testing COPD patients.
About one third of the attendees reported that the differ-
entiation between asthma and COPD was difﬁ  cult (n = 108, 
38%) while over three-quarters, 78%, stated that COPD was 
primarily a disease of men and over half (61%) said that the 
COPD generally started at or after age 60.
While only 6% of the respondents reported that “lack of 
adequate treatment for COPD” was a barrier to diagnosis 
of COPD, few were optimistic about the value of COPD 
treatments. Overall, 15% stated that COPD treatment was 
somewhat or very useful for improving symptoms, and 3% 
thought that treatment was useful or very useful for decreas-
ing the risk of exacerbations yet 13% stated that they thought 
COPD treatment could increase longevity. Beliefs about the 
value of COPD treatments did not vary signiﬁ  cantly by site 
or training level.
Pulmonary rehabilitation was available to 32% of the 
attendees but only 3% thought rehabilitation was useful or 
very useful for COPD patients with another 16% saying they 
are neutral about the beneﬁ  ts of pulmonary rehabilitation. 
Beliefs about the value of pulmonary rehabilitation did not 
vary by site although pulmonary rehabilitation services had 
signiﬁ  cantly higher availability for respondents in Costa 
Mesa, CA and Chicago, IL than in Raleigh, NC (32% and 
28% vs 5%, respectively, p = 0.01).
Use of GOLD or ATS/ERS guidelines, use of broncho-
dilator reversibility or spirometry testing in COPD diagnosis 
were examined for associations with demographic and ofﬁ  ce 
characteristics through multivariable logistic regression. Few 
associations were found. In particular, no signiﬁ  cant associa-
tions were found with age, gender, experience, size of practice, 
or size of local population. MD’s were more likely than NP/
PAs to use bronchodilator reversibility in diagnosis (OR = 2.1, 
p = 0.005). Spirometry was more likely to be used in diagnosis 
when the ofﬁ  ce had a spirometer (OR = 3.7, p  0.0001). 
Table 1 Demographics
Type of health  Medical  Nurse practitioner/
professional doctor  Physician’s  assistant
Median age  50–59  40–49
% women  42%  86%
Median tears in practice  16–25  5–15
Had spirometry in ofﬁ  ce  55%  55%
Used reversibility or post  38%  23%
bronchodilator testing
for diagnosis
Reports lack of  39 (22%)  33 (33%)
knowledge as a barrier
Table 2 Use of guidelines with respondent characteristics 
Type of health  Medical doctor  Nurse practitioner/  Has spirometry  Age 50 Age  50
professional n  = 178  Physician’s assistant n = 100  in ofﬁ  ce n = 148  n = 149  n = 130
Uses GOLD or ATS COPD  56 (31%)  34 (34%)  62 (42%)  47 (32%)  42 (32%)
guidelines
Uses none or does not know  59 (33%)  40 (40%)  43 (29%)  59 (40%)  42 (45%)International Journal of COPD 2008:3(2) 314
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And GOLD or ATS guidelines were more likely to be used 
when the ofﬁ  ce had a spirometer (OR = 2.4, p = 0.002).
Discussion
The health professionals attending these conferences report 
that almost half of them used either the GOLD or ATS/ERS 
guidelines for COPD diagnosis and management. Most 
of the other attendees (40%) were unaware of any COPD 
care guidelines or stated that they used the NAEPP (asthma) 
guidelines for COPD management. Even without use of 
guidelines, almost three-quarters of the attendees stated they 
used spirometry to diagnosis COPD with only about one 
third reporting inclusion of pre- and post-bronchodilator 
testing to make the diagnosis. This suggests that two-thirds 
do not consider lack of reversibility a necessary criteria 
for COPD diagnosis. This is comparable with awareness 
of COPD guidelines but higher reported COPD guideline 
and spirometry use than reported by Barr and colleagues 
(2005).
The attendees expressed considerable pessimism in the 
ability of medical therapy to improve symptoms or pre-
vent exacerbations. Yet 15% felt that COPD therapy could 
improve longevity. These results suggest signiﬁ  cant oppor-
tunities for education and improvements in use of tools to 
improve COPD recognition and management.
The reported use of spirometry among these attendees 
was higher than has been reported among family physicians 
in previous studies (Fauzi 2003; Dowd et al 2003; Diaz-
Lobato et al 2004; Caramori et al 2005; Fried et al 2005; 
Kaminsky et al 2005; Walters et al 2005; Lusuardi et al 
2006). It is possible that this is due to the large metropolitan 
communities in which these presentations were given, the 
presence of nonphysician clinicians who worked in specialty 
departments in primary care ofﬁ  ces or to an increase accep-
tance of the value and importance of spirometry over the 
past 5 to 8 years. Several recent publications have supported 
the availability and positive impact of spirometry testing in 
family or general practices (Nihlen et al 2003; Schermer 
et al 2003; Buffels et al 2004; Bolton et al 2005; Walker et al 
2006; Tinkelman et al 2007; Yawn et al 2007). Since COPD 
was only one of ﬁ  ve topics covered during these day-long 
sessions, it seems illogical to assume that all attendees had 
a special interest in COPD.
Less than half of the physicians and other clinicians who 
say they use spirometry to diagnose COPD reported they 
included reversibility or post bronchodilation assessment in 
the diagnostic evaluation. This is not consistent with COPD 
guidelines that list the lack of signiﬁ  cant reversibility as a 
hallmark and part of the deﬁ  nition of COPD (ATS 2004; 
GOLD 2007; Hurst and Wedzicha 2007).
About half of the physicians and other clinicians expressed 
concern that their patients fail to report COPD-related 
symptoms even though most respondents said they used 
symptoms of dyspnea with activity or at rest to diagnose COPD. 
This concern echoes that of other physicians around the world. 
To deal with this concern, several questionnaire-based COPD 
screening tools have been developed and tested in general 
practice patients (Freeman et al 2005; van Schayck et al 2005; 
Price et al 2006). Most of these surveys query patients about 
chronic productive cough, shortness of breath with exercise, 
increasing exercise intolerance, and smoking behavior. The 
need for these questionnaires is based on the premise that 
patients are often not forth-coming about symptoms and that 
without tools physicians and other clinicians often fail to ask 
Table 3 Use of signs and symptoms and tests to diagnose COPD
Type of  Spirometry  Pre and post  Symptoms   Smoking  Chest  Trial of  Trial of
training    broncho-dilator  (any of three)  history  radiograph  corticosteroids  broncho-dilators
MD n = 178  138 (78%)  56 (31%)  120 (67%)  118 (66%)  109 (61%)  22 (12%)  56 (31%)
NP/PA n = 100  74 (74%)  23 (23%)  61 (61%)  59 (59%)  59 (59%)  7 (7%)  23 (23%)
Abbreviations: MD, medical doctor; NP, nursing practitioner; PA, physician’s assistant.
Table 4 Perceived barriers in the diagnosis of COPD
Type of  Lack of speciﬁ  c  Failure of patients  Multiple  Lack of  Lack of  Lack of
health professional  symptoms  to recognize  chronic   knowledge  access to  effective
    and report dyspnea  conditions  and training  spirometry  treatment
MD n = 178  35 (20%)  85 (48%)  80 (45%)  39 (22%)  51 (29%)  13 (7%)
NP/Pas n = 100  22 (22%)  50 (50%)  64 (64%)  33 (33%)  21 (21%)  5 (5%)
Abbreviations: MD, medical doctor; NP, nursing practitioner; PA, physician’s assistant.International Journal of COPD 2008:3(2) 315
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about speciﬁ  c symptoms (Freeman et al 2005; van Schayck et al 
2005; Garcia-Aymerich et al 2006; Price et al 2006). The recent 
and ongoing NHLBI public awareness campaign is also based 
on this premise and uses many formats and types of media to 
help raise awareness of symptoms that patients should report to 
their physician or other clinician (see www.COPD-medications.
gov, www.COPD-guidebook.gov).
The depth of the pessimism about the outcome of COPD 
treatment was disappointing. Primary care physicians often 
report cases of patients diagnosed with COPD whom the 
physician was unable to “help” except with terminal illness 
planning. Although some pessimism may be appropriate, 
it was surprising and inconsistent with reported data, that 
over 84% of health care professionals reported that they felt 
pharmacotherapy had no effect on COPD symptom reduc-
tion or reduction of exacerbations (Appleton et al 2000; 
Calverley 2000; Van Noord et al 2000; Pauwels et al 2001; 
Barnes 2002; Anzueto et al 2005; Cazzola et al 2005; Kesten 
and O’Donnel 2005; Calverley et al 2007). In addition, the 
attitude toward and use of pulmonary rehabilitation was very 
low. While availability was limited (32% reported avail-
ability) use was even lower. Recent data clearly shows the 
beneﬁ  ts of pulmonary rehabilitation (Paz-Diaz et al 2007; 
Ries et al 2007; Birnbaum and Carlin 2008). Additionally, 
education regarding the components and beneﬁ  ts of pulmo-
nary rehabilitation and better reimbursement opportunities 
for these services could increase its inclusion in COPD man-
agement by primary care physicians. Conversely, the 15% 
of respondents who reported that COPD improved longevity 
may be over-optimistic. The optimism might be explained 
by attendees including smoking cessation and oxygen therapy 
in their group of COPD treatments that increase longevity 
(Anthonisen et al 1994).
COPD is not a disease of men and often begins before age 
60, unlike the beliefs expressed by over 60% of the attendees. 
Beginning in 2000, more women than men die each year of 
COPD (Buist et al 2007; Mannino and Buist 2007) and COPD 
often begins in the patient’s 40s or 50s. Early symptoms may 
go unnoticed including the early changes in activity levels 
and exertion that are the adaptations made to deal with early 
COPD (Chavannes et al 2004; Freeman et al 2005; Levy et al 
2006; Price et al 2006; GOLD 2007; Hurst and Wedzicha 
2007; USPSTF 2007). The clinicians’ misperceptions again 
suggest opportunities for education and potentially changes 
who and how patients are assessed for COPD.
A significant percent of the attendees recognized 
and reported a gap in their training about the diagnosis 
and management of COPD. Training related to COPD and 
its diagnosis through use of pre- and post-bronchodilator 
spirometry testing should begin in medical school (Yawn 
and Yawn 2005) and be supplemented in residency training 
and in continuing medical education. Physicians who had 
completed training within the past 15 years were no more 
likely than those completing training more than 15 year ago 
to report use of spirometry or reversibility testing to diagnose 
COPD, which suggests that more recent training is still not 
addressing this issue sufﬁ  ciently. The ability to ﬁ  t additional 
COPD training into the more limited training time available 
to NPs and PAs will require very careful consideration of 
their role in COPD management.
This study is not large. However, the results are compara-
ble to those of previous larger studies of US physicians (Barr 
et al 2005). The generalizability of the results are limited by 
the inclusion of only 3 geographic sites and by the 37% of 
attendees who did not return the survey. It is also possible 
that the attendees had a special interest in COPD. However, 
this seems unlikely since COPD was only one of ﬁ  ve chronic 
diseases covered during the one day session. Generalizability 
from the full sample may also be limited by the large number 
of non-physician clinicians in attendance, a percent signiﬁ  -
cantly higher than in US clinic practice. For example, NP/PAs 
were less likely than physicians to report using reversibility 
testing in making the diagnosis of COPD.
In summary, COPD is the fourth leading cause of 
death in the US and among the top 10 reasons patients 
visit a family physician. While the data from this survey is 
encouraging in the rate of reported use of spirometry testing 
for COPD diagnosis, awareness of COPD guidelines and 
pessimism regarding the beneﬁ  ts of treating COPD, the 
infrequent use of reversibility testing for COPD diagnosis, 
and the over 40% of attendees who do not use and are not 
even aware of COPD guidelines should be the basis for 
a review of our medical and nursing education regarding 
COPD during initial training and in continuing education 
programs.
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